{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:43:53Z","timestamp":1792763033209,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Opening Project of Fujian Key Laboratory of Lung Stem Cells","award":["Grant no. FGXB202403"],"award-info":[{"award-number":["Grant no. FGXB202403"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["Grant no. 2024J011162"],"award-info":[{"award-number":["Grant no. 2024J011162"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Innovation Joint Funding Project of Fujian Province","award":["Grant no.2025Y9731"],"award-info":[{"award-number":["Grant no.2025Y9731"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01945-6","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:10:41Z","timestamp":1782702641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell transcriptomic analysis identifies a tumor-enriched GIMAP7\u207a CD4\u207a na\u00efve T cell population with a unique immunoregulatory state in lung adenocarcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Zhirong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzhe","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"1945_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-022-01041-x","volume":"14","author":"E Adib","year":"2022","unstructured":"Adib E, Nassar AH, Abou Alaiwi S, Groha S, Akl EW, Sholl LM, Michael KS, Awad MM, J\u04d3nne PA, Gusev A et al (2022) Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology. Genome Med 14:39","journal-title":"Genome Med"},{"key":"1945_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.semnuclmed.2025.02.009","volume":"55","author":"F Alorfi","year":"2025","unstructured":"Alorfi F, Bomanji J, Bertoletti L, Fraioli F (2025) PET\/MRI in Non-Small Cell Lung Cancer (NSCLC). Semin Nucl Med 55:234\u2013239","journal-title":"Semin Nucl Med"},{"key":"1945_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12967-025-06167-1","volume":"23","author":"Q An","year":"2025","unstructured":"An Q, Duan L, Wang Y, Wang F, Liu X, Liu C, Hu Q (2025) Role of CD4\u2009+\u2009T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment. J Translational Med 23:179","journal-title":"J Translational Med"},{"key":"1945_CR33","doi-asserted-by":"publisher","first-page":"102345","DOI":"10.1016\/j.coi.2023.102345","volume":"83","author":"E Bawden","year":"2023","unstructured":"Bawden E, Gebhardt T (2023) The multifaceted roles of CD4(+) T cells and MHC class II in cancer surveillance. Curr Opin Immunol 83:102345","journal-title":"Curr Opin Immunol"},{"key":"1945_CR27","doi-asserted-by":"crossref","unstructured":"Benoit-Lizon I, Jacquin E, Rivera Vargas T, Richard C, Roussey A, Dal Zuffo L, Martin T, Melis A, Vinokurova D, Shahoei SH et al (2022) CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T(H)1 and T(H)9 cells. J Immunother Cancer 10","DOI":"10.1136\/jitc-2021-003459"},{"key":"1945_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jss.2005.02.020","volume":"127","author":"U Bharadwaj","year":"2005","unstructured":"Bharadwaj U, Zhang R, Yang H, Li M, Doan LX, Chen C, Yao Q (2005) Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation. J Surg Res 127:29\u201338","journal-title":"J Surg Res"},{"key":"1945_CR12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1200\/JCO.22.01503","volume":"41","author":"JR Brahmer","year":"2023","unstructured":"Brahmer JR, Lee JS, Ciuleanu TE, Bernabe Caro R, Nishio M, Urban L, Audigier-Valette C, Lupinacci L, Sangha R, Pluzanski A et al (2023) Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227. J Clin Oncol 41:1200\u20131212","journal-title":"J Clin Oncol"},{"key":"1945_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"1945_CR18","doi-asserted-by":"publisher","first-page":"218076","DOI":"10.1016\/j.canlet.2025.218076","volume":"634","author":"Q Chen","year":"2025","unstructured":"Chen Q, Jiang K, Bronze MS, Li M, Houchen CW, Zhang Y (2025) Tumor microenvironment and macroenvironment: A new perspective on holistic oncology. Cancer Lett 634:218076","journal-title":"Cancer Lett"},{"key":"1945_CR30","doi-asserted-by":"publisher","first-page":"e70433","DOI":"10.1002\/ctm2.70433","volume":"15","author":"J Choe","year":"2025","unstructured":"Choe J, Lim J, Kang N, Seo ES, Hwang M, Han KY, Lee SH, Ahn MJ, Choi YL, Kim HK et al (2025) Novel cancer-associated secretory cells and IL-1\u03b2(+) macrophages as key players in early lung adenocarcinoma progression in female never-smokers. Clin Transl Med 15:e70433","journal-title":"Clin Transl Med"},{"key":"1945_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/1759-7714.13208","volume":"11","author":"Y Ding","year":"2020","unstructured":"Ding Y, Zhang L, Guo L, Wu C, Zhou J, Zhou Y, Ma J, Li X, Ji P, Wang M et al (2020) Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients. Thorac Cancer 11:103\u2013112","journal-title":"Thorac Cancer"},{"key":"1945_CR43","doi-asserted-by":"publisher","first-page":"9341","DOI":"10.3390\/ijms23169341","volume":"23","author":"JM Han","year":"2022","unstructured":"Han JM, Jung HJ, Cyclophilin (2022) A\/CD147 Interaction: A Promising Target for Anticancer Therapy. Int J Mol Sci 23:9341","journal-title":"Int J Mol Sci"},{"key":"1945_CR15","doi-asserted-by":"publisher","first-page":"10285","DOI":"10.21037\/jtd-2025-1404","volume":"17","author":"BS Hendriksen","year":"2025","unstructured":"Hendriksen BS, Ortiz BA, Wigle DA, Cassivi SD, Saddoughi SA, Puig CA, Shen KR, Reisenauer JS, Tapias LF (2025) Risk factors and survival associated with lung cancer recurrence after curative-intent surgery: beyond TNM pathological staging. J Thorac Disease 17:10285\u201310297","journal-title":"J Thorac Disease"},{"key":"1945_CR36","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1172\/JCI42758","volume":"120","author":"KM Hertoghs","year":"2010","unstructured":"Hertoghs KM, Moerland PD, van Stijn A, Remmerswaal EB, Yong SL, van de Berg PJ, van Ham SM, Baas F, ten Berge IJ, van Lier RA (2010) Molecular profiling of cytomegalovirus-induced human CD8\u2009+\u2009T cell differentiation. J Clin Invest 120:4077\u20134090","journal-title":"J Clin Invest"},{"key":"1945_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.chest.2025.06.023","volume":"168","author":"J Howington","year":"2025","unstructured":"Howington J, Souter LH, Arenberg D, Blasberg J, Detterbeck F, Farjah F, Lanuti M, Leighl N, Videtic GM, Murthy S (2025) Management of Patients With Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline. Chest 168:810\u2013827","journal-title":"Chest"},{"key":"1945_CR25","first-page":"xxiii","volume":"New York","author":"C Janeway","year":"2005","unstructured":"Janeway C (2005) Immunobiology: the immune system in health and disease, 6th ed. Garland Sci New York:xxiii\u2013823p","journal-title":"Garland Sci"},{"key":"1945_CR13","doi-asserted-by":"publisher","first-page":"102315","DOI":"10.1016\/j.xcrm.2025.102315","volume":"6","author":"K Kang","year":"2025","unstructured":"Kang K, Liu S, Yao Z, Xue J, Lu Y (2025) Addressing clinical needs in NSCLC immunotherapy: Mechanisms of resistance and promising combination strategies. Cell Rep Med 6:102315","journal-title":"Cell Rep Med"},{"key":"1945_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jtho.2025.03.033","volume":"20","author":"S Kilickap","year":"2025","unstructured":"Kilickap S, Baramidze A, Sezer A, \u00d6zg\u00fcro\u011flu M, Gumus M, Bondarenko I, Gogishvili M, Nechaeva M, Schenker M, Cicin I et al (2025) Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1. J Thorac Oncol 20:941\u2013954","journal-title":"J Thorac Oncol"},{"key":"1945_CR16","doi-asserted-by":"publisher","first-page":"114642","DOI":"10.1016\/j.yexcr.2025.114642","volume":"450","author":"Y Kim","year":"2025","unstructured":"Kim Y, Park D, Lee D, Chung C (2025) Tissue is the issue: overcoming limitations in lung cancer precision medicine through cryobiopsy-derived lung cancer organoids and organ-on-a-chip models. Exp Cell Res 450:114642","journal-title":"Exp Cell Res"},{"key":"1945_CR34","doi-asserted-by":"crossref","unstructured":"Lauder E, Gondal M, Wu M-C, Yamamoto A, Maneix L, Zhao D, Sun Y, Cieslik M, Chinnaiyan AM, Reddy P (2026) MHC class I on target cells regulates CD4\u2009+\u2009T cell-mediated immunity. Nat Immunol27(5):1000-1012","DOI":"10.1038\/s41590-026-02480-z"},{"key":"1945_CR38","doi-asserted-by":"publisher","first-page":"e3002943","DOI":"10.1371\/journal.pbio.3002943","volume":"22","author":"ML Lawton","year":"2024","unstructured":"Lawton ML, Inge MM, Blum BC, Smith-Mahoney EL, Bolzan D, Lin W, McConney C, Porter J, Moore J, Youssef A et al (2024) Multiomic profiling of chronically activated CD4\u2009+\u2009T cells identifies drivers of exhaustion and metabolic reprogramming. PLoS Biol 22:e3002943","journal-title":"PLoS Biol"},{"key":"1945_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1186\/s12967-024-05530-y","volume":"22","author":"R Liu","year":"2024","unstructured":"Liu R, Yang G, Guo H, Chen F, Lu S, Zhu H (2024) Roles of na\u00efve CD4(+) T cells and their differentiated subtypes in lung adenocarcinoma and underlying potential regulatory pathways. J Transl Med 22:781","journal-title":"J Transl Med"},{"key":"1945_CR22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s13402-024-00948-4","volume":"47","author":"S Mao","year":"2024","unstructured":"Mao S, Wang Y, Chao N, Zeng L, Zhang L (2024) Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma. Cell Oncol (Dordr) 47:1697\u20131713","journal-title":"Cell Oncol (Dordr)"},{"key":"1945_CR23","doi-asserted-by":"publisher","first-page":"143056","DOI":"10.1016\/j.ijbiomac.2025.143056","volume":"309","author":"S Mao","year":"2025","unstructured":"Mao S, Chen L, Li Q, Zhang L, Zhao H, Lin Y (2025) Unveiling hypoxia-related prognostic and immunotherapeutic biomarkers in lung adenocarcinoma through single-cell and bulk RNA sequencing: Including insights into PGF. Int J Biol Macromol 309:143056","journal-title":"Int J Biol Macromol"},{"key":"1945_CR21","doi-asserted-by":"publisher","first-page":"9927","DOI":"10.21037\/jtd-2025-1224","volume":"17","author":"F Meng","year":"2025","unstructured":"Meng F, Sun Y, Li J, Xu L (2025) Single-cell and spatial transcriptome landscapes reveal the spatial immune defense pattern shared by primary and brain metastatic lung adenocarcinoma. J Thorac Disease 17:9927\u20139942","journal-title":"J Thorac Disease"},{"key":"1945_CR42","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","volume":"22","author":"N Pishesha","year":"2022","unstructured":"Pishesha N, Harmand TJ, Ploegh HL (2022) A guide to antigen processing and presentation. Nat Rev Immunol 22:751\u2013764","journal-title":"Nat Rev Immunol"},{"key":"1945_CR8","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s00330-025-11910-9","volume":"36","author":"MP Revel","year":"2026","unstructured":"Revel MP, Biederer J, Nair A, Silva M, Jacobs C, Snoeckx A, Prokop M, Prosch H, Parkar AP, Frauenfelder T et al (2026) ESR Essentials: lung cancer screening with low-dose CT-practice recommendations by the European Society of Thoracic Imaging. Eur Radiol 36:2064\u20132073","journal-title":"Eur Radiol"},{"key":"1945_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.str.2013.01.014","volume":"21","author":"D Schwefel","year":"2013","unstructured":"Schwefel D, Arasu BS, Marino SF, Lamprecht B, K\u00f6chert K, Rosenbaum E, Eichhorst J, Wiesner B, Behlke J, Rocks O et al (2013) Structural insights into the mechanism of GTPase activation in the GIMAP family. Structure 21:550\u2013559","journal-title":"Structure"},{"key":"1945_CR39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41423-023-01031-y","volume":"20","author":"A Sharma","year":"2023","unstructured":"Sharma A, Schmidt-Wolf IGH (2023) Tempering of exhausted T cells to comprehend their adaptive response for suitable clinical translation. Cell Mol Immunol 20:1401\u20131402","journal-title":"Cell Mol Immunol"},{"key":"1945_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/epidemiologia5040053","volume":"5","author":"R Sharma","year":"2024","unstructured":"Sharma R, Khubchandani J, Global (2024) Regional, and National Burden of Tracheal, Bronchus, and Lung Cancer in 2022: Evidence from the GLOBOCAN Study. Epidemiologia 5:785\u2013795","journal-title":"Epidemiologia"},{"key":"1945_CR4","doi-asserted-by":"publisher","first-page":"946625","DOI":"10.3389\/fonc.2022.946625","volume":"12","author":"H Shi","year":"2022","unstructured":"Shi H, Seegobin K, Heng F, Zhou K, Chen R, Qin H, Manochakian R, Zhao Y, Lou Y (2022) Genomic landscape of lung adenocarcinomas in different races. Front Oncol 12:946625","journal-title":"Front Oncol"},{"issue":"6","key":"1945_CR19","first-page":"e70496","volume":"2025","author":"Y Sun","year":"2020","unstructured":"Sun Y, Shao C, Duan H, Wang Z, Xu S, Wang C, Xiu J, Liu J, Wang X, Yao X et al (2020) Dynamic Evolution of the Tumor Immune Microenvironment in Malignant Tumors and Emerging Therapeutic Paradigms. MedComm 2025(6):e70496","journal-title":"MedComm"},{"key":"1945_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/cam4.4933","volume":"12","author":"J Thaiparambil","year":"2023","unstructured":"Thaiparambil J, Dong J, Grimm SL, Perera D, Ambati CSR, Putluri V, Robertson MJ, Patel TD, Mistretta B, Gunaratne PH et al (2023) Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer. Cancer Med 12:584\u2013596","journal-title":"Cancer Med"},{"key":"1945_CR29","doi-asserted-by":"publisher","first-page":"638374","DOI":"10.3389\/fcell.2021.638374","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li X, Peng S, Hu H, Wang Y, Shao M, Feng G, Liu Y, Bai Y (2021) Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma. Front Cell Dev Biol 9:638374","journal-title":"Front Cell Dev Biol"},{"key":"1945_CR14","doi-asserted-by":"publisher","first-page":"2574526","DOI":"10.1080\/07853890.2025.2574526","volume":"57","author":"J Wang","year":"2025","unstructured":"Wang J, Wang J, Chen J (2025) Precision navigation through the labyrinth: overcoming EGFR resistance in non-Small cell lung cancer. Ann Med 57:2574526","journal-title":"Ann Med"},{"key":"1945_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cancers18020216","volume":"18","author":"M Winter","year":"2026","unstructured":"Winter M, Jeroch J, Wetz M, Rauschendorf M-A, Wild PJ (2026) Molecular Pathology of Advanced NSCLC: Biomarkers and Therapeutic Decisions. Cancers 18:216","journal-title":"Cancers"},{"key":"1945_CR41","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1038\/onc.2010.260","volume":"29","author":"MJ Wolf","year":"2010","unstructured":"Wolf MJ, Seleznik GM, Zeller N, Heikenwalder M (2010) The unexpected role of lymphotoxin \u03b2 receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene 29:5006\u20135018","journal-title":"Oncogene"},{"key":"1945_CR37","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/2211-5463.12861","volume":"10","author":"T Yashiro","year":"2020","unstructured":"Yashiro T, Takeuchi H, Kasakura K, Nishiyama C (2020) PU.1 regulates Ccr7 gene expression by binding to its promoter in na\u00efve CD4(+) T cells. FEBS Open Bio 10:1115\u20131121","journal-title":"FEBS Open Bio"},{"key":"1945_CR17","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.21037\/tcr-2025-1332","volume":"14","author":"JK Yoon","year":"2025","unstructured":"Yoon JK, Park JY, Kim YW, Oh HJ, Kim YC (2025) Advances and challenges in circulating tumor DNA-based early detection of lung cancer. Transl Cancer Res 14:7428\u20137437","journal-title":"Transl Cancer Res"},{"key":"1945_CR28","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/s41467-025-57237-3","volume":"16","author":"JW Yoon","year":"2025","unstructured":"Yoon JW, Kim KM, Cho S, Cho MJ, Park S, Hwang D, Kim HR, Park SH, Cho JH, Jeong H et al (2025) Th1-poised naive CD4 T cell subpopulation reflects anti-tumor immunity and autoimmune disease. Nat Commun 16:1962","journal-title":"Nat Commun"},{"key":"1945_CR20","doi-asserted-by":"publisher","first-page":"983570","DOI":"10.3389\/fimmu.2022.983570","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Jiang B, Lan Z, Yang C, Yao Y, Lin J, Wei Q (2022) Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma. Front Immunol 13:983570","journal-title":"Front Immunol"},{"key":"1945_CR32","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, Ren X, Wang L, Wu X, Zhang J et al (2021) Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374:abe6474","journal-title":"Science"},{"key":"1945_CR7","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.canep.2024.102693","volume":"93","author":"J Zhou","year":"2024","unstructured":"Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D (2024) Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol 93:102693","journal-title":"Cancer Epidemiol"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01945-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:10:50Z","timestamp":1782702650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01945-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01945-6","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The study protocol received approval from the Ethics Committee of the 900th Hospital of the Joint Logistic Support Force of the People\u2019s Liberation Army (Approval No. 2023-013). Written informed consent was obtained from each patient or their legal guardians, and all procedures strictly complied with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the manuscript and agreed to its publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}